NCT07599176 Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors Status RECRUITING Phase PHASE1/PHASE2
NCT07562451 Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing Status NOT_YET_RECRUITING Phase NA
NCT07540767 Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Status NOT_YET_RECRUITING Phase NA
NCT07498309 Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease Status NOT_YET_RECRUITING Phase PHASE3
NCT07450430 Optimal Timing of Ketamine Initiation for SCD Pain Status NOT_YET_RECRUITING Phase PHASE3
NCT07436767 Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease Status NOT_YET_RECRUITING Phase NA
NCT07432867 Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA. Status RECRUITING Phase PHASE1/PHASE2
NCT07431398 Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease Status RECRUITING Phase PHASE1
NCT07402811 Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease Status RECRUITING Phase NA
NCT07401823 Open-Label Extension Study to Pioneer Study 6058-SCD-101 Status ENROLLING_BY_INVITATION Phase PHASE2
NCT07373639 A Long-term Follow-up Study in Patients Who Received BEAM-101 Status RECRUITING Phase N/A
NCT07369024 Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults Status RECRUITING Phase PHASE2
NCT07356050 Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease Status RECRUITING Phase N/A
NCT07341022 STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07316478 Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease Status RECRUITING Phase NA
NCT07282210 Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype Status NOT_YET_RECRUITING Phase PHASE2